PALI

Palisade Bio Stock Price

4.18
0.25 (6.36%)
Upgrade to Real-Time
Afterhours (Closed)
4.18

Low
3.43

52 Week Range

High
10.91

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Palisade Bio Inc PALI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.25 6.36% 4.18 19:48:41
Open Price Low Price High Price Close Price Prev Close
4.04 3.96 4.15 4.11 3.93
Bid Price Ask Price Spread News
4.15 4.22 0.07 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,163 599,649 $ 4.05 $ 2,426,208 2,069,783 3.43 - 10.91
Last Trade Time Type Quantity Stock Price Currency
19:58:06 8 $ 4.18 USD

Palisade Bio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 30.52M 7.30M 17.26M $ - $ - -1.45 -1.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 864.66k 0.10%

more financials information »

Palisade Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PALI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.134.293.754.04787,8750.051.21%
1 Month4.1074.373.433.85931,9660.0731.78%
3 Months9.0010.913.434.552,000,692-4.82-53.56%
6 Months9.0010.913.434.552,000,692-4.82-53.56%
1 Year9.0010.913.434.552,000,692-4.82-53.56%
3 Years9.0010.913.434.552,000,692-4.82-53.56%
5 Years9.0010.913.434.552,000,692-4.82-53.56%

Palisade Bio Description

Palisade Bio Inc is a late-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.


Your Recent History
NASDAQ
PALI
Palisade B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.